Home › Research › Tau biomarkers
Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Wei HC, Li B, Ng KP, Fu QX, Dong SJ, Ba MW, Kong M.. Chinese medical journal, 2021-07-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background According to the amyloid, tau, neurodegeneration research framework classification, amyloid and tau positive (A+T+) mild cognitive impairment (MCI) individuals are defined as prodromal Alzheimer disease. This study was designed to compare the clinical and biomarker features between A+T+MCI individuals who progressed to progressive MCI (pMCI) and those who remained stable MCI (sMCI), and to identify relevant baseline clinical biomarker and features that could be used to predict progression to dementia within 2 years. Methods We stratified 197 A+T+MCI individuals into pMCI (n = 64) and sMCI (n = 133) over 2 years.
What this study adds
Evidence grade: Low
The record lists 64 participants. This study compared clinical and biomarker features between people with mild cognitive impairment who progressed to dementia and those who remained stable, to identify predictors of progression within 2 years. It is an observational study and does not test any treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wei, H. C., Li, B., Ng, K. P., Fu, Q. X., Dong, S. J., Ba, M. W., et al. (2021). Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression. Chinese medical journal. https://doi.org/10.1097/cm9.0000000000001496
Vancouver
Wei HC, Li B, Ng KP, Fu QX, Dong SJ, Ba MW, et al. Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression. Chinese medical journal. 2021. doi:10.1097/cm9.0000000000001496. PMID: 34397597.
BibTeX
@article{wei2021-34397597,
author = {Wei, H. C. and Li, B. and Ng, K. P. and Fu, Q. X. and Dong, S. J. and Ba, M. W. and Kong, M.},
title = {{Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression}},
journal = {Chinese medical journal},
year = {2021},
doi = {10.1097/cm9.0000000000001496},
pmid = {34397597},
url = {https://doi.org/10.1097/cm9.0000000000001496}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- This study was designed to compare the clinical and biomarker features between A+T+MCI individuals who progressed to progressive MCI (pMCI) and those who remained stable MCI (sMCI), and to identify relevant baseline clinical biomarker and features that could be used to predict progression to dementia within 2 years.
- Methods We stratified 197 A+T+MCI individuals into pMCI (n = 64) and sMCI (n = 133) over 2 years.
- Demographics and cognitive assessment scores, cerebrospinal fluid (CSF), and neuroimaging biomarkers (18F-florbetapir positron emission tomography mean standardized uptake value ratios [SUVR] and structural magnetic resonance imaging [MRI]) were compared between pMCI and sMCI at baseline, 12- and 24-month follow-up.
- Logistic regression models then were used to evaluate clinical baseline and biomarker features that predicted dementia progression in A+T+MCI.
Why it matters
This study compared clinical and biomarker features between people with mild cognitive impairment who progressed to dementia and those who remained stable, to identify predictors of progression within 2 years. It is an observational study and does not test any treatment or cure.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants64
- Evidence strengthLow
How this study scored 39/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Chinese medical journal) |
| Journal's citation record | 1 / 4 | Chinese Medical Journal: journal h-index 94 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 1 / 4 | 64 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 10 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.4 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Min Kong: h-index 13 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Qingdao University: institution h-index 430 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 34397597) |
| Free to read | 2 / 2 | Free to read |
| Total | 39 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1097/cm9.0000000000001496
- PubMed: 34397597
- Original source →
- Free full text: Chinese Medical Journal →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 23.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.